Endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble CD14 but are activated indirectly by peptidoglycan-induced tumor necrosis factor-α and interleukin-1 from monocytes

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1629-1638

  Jin, Yiping ^a,b   Gupta, Dipika ^a   Dziarski, Roman ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031777042     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515318     Document Type: Article

References (19)

1. Schleifer KH, Kandler O. Peptidoglycan types in the bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972;36:407-77.
2. Heymer B, Seidl PH, Schleifer KH. Immunochemistry and biological activity of peptidoglycan. In: Stewart-Tull DES, Davies M, eds. Immunology of the bacterial cell envelope. New York: John Wiley & Sons, 1985:11-46.
3. Dziarski R. In: Seidl HP, Schleifer KH, eds. Biological properties of peptidoglycan. Berlin: Walter De Gruyter, 1986:229-47.
4. Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990;59:129-70.
5. Rosenthal RS, Dziarski R. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol 1994;235:253-85.
6. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995;92:10359-63.
7. Gupta D, Jin Y, Dziarski R. Peptidoglycan induces transcription and secretion of TNF-α and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages. J Immunol 1995;155:2620-30.
8. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
9. Wahl SM, Feldman GM, McCarthy JB. Regulation of leukocyte adhesion and signaling in inflammation and disease. J Leukoc Biol 1996;59:789-96.
10. Frey EA, Miller DS, Jahr TG, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-71.
11. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90:2744-8.
12. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 1993;151:1500-7.
13. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 1993;90:9887-91.
14. Arditi M, Zhou J, Dorio R, Rong GW, Goyert SM, Kim KS. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun 1993;61:3149-56.
15. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990;249:1431-3.
16. Ulevitch RJ, Tobias PS. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-57.
17. Hailman E, Lichenstein HS, Wurefel MM, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994;179:269-77.
18. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995;270:5320-5.
19. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996;4:407-14.